| Low strength (HR, 95% CI) | High strength (HR, 95% CI) | ||
---|---|---|---|---|
Outcome | Model I* | Model II†| Model I* | Model II†|
Middle age‡ morbidity |  |  |  |  |
 CVD events§ | 0.99 (0.88 to 1.10) | 0.99 (0.86 to 1.13) | 0.91 (0.81 to 1.02) | 0.88 (0.77 to 0.99) |
Middle age mortality | Â | Â | Â | Â |
 CVD | 1.23 (1.01 to 1.51) | 1.31 (1.02 to 1.67) | 1.11 (0.92 to 1.34) | 0.98 (0.78 to 1.24) |
 All-cause | 1.17 (1.06 to 1.29) | 1.18 (1.04 to 1.33) | 1.03 (0.94 to 1.14) | 0.98 (0.87 to 1.10) |
Total|| mortality | Â | Â | Â | Â |
 CVD | 1.28 (1.06 to 1.55) | 1.21 (0.96 to 1.51)¶ | 1.08 (0.90 to 1.30) | 1.03 (0.84 to 1.28)¶ |
 All-cause | 1.16 (1.07 to 1.27) | 1.14 (1.03 to 1.26)¶ | 1.03 (0.95 to 1.12) | 1.04 (0.95 to 1.15)¶ |